GPX4 and colorectal carcinoma: In conclusion, we first demonstrated that a novel combination treatment regimen consisting of curcumin and andrographis exhibited anti-tumorigenic effects in CRC through ferroptosis caused by dual suppression of GPX-4 and FSP-1.